[DNA repair as a therapeutic target]

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• DNA repair systems ensure genetic code stability during cell division.
• Mutations in DNA repair genes can lead to cancer predisposition and genomic instability in cancer cells.
• Cancer cells' increased susceptibility to DNA damage presents a therapeutic vulnerability.

Purpose of the Study:

• To elucidate the mechanisms of various DNA repair pathways.
• To detail the proteins involved in DNA repair and their link to cell-cycle checkpoints.
• To review novel therapeutic agents targeting DNA repair, their clinical outcomes, and combination therapy challenges.

Main Methods:

• Review of DNA repair pathways and associated proteins.
• Analysis of cell-cycle checkpoint interactions with DNA repair.
• Examination of clinical data for novel DNA repair-targeting agents.

Main Results:

• DNA repair pathways are essential for maintaining genomic integrity.
• Defects in DNA repair pathways contribute to cancer development and progression.
• Targeting DNA repair, such as with PARP inhibitors in BRCA-mutated cancers, demonstrates clinical efficacy.

Conclusions:

• Exploiting cancer cell DNA repair deficiencies offers a viable therapeutic approach.
• Novel agents targeting DNA repair pathways show promise in cancer treatment.
• Further research into combination therapies is needed to overcome resistance and improve outcomes.